Artículos de revistas sobre el tema "Nalm6 cells"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Nalm6 cells".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Ramírez Saldaña, Maricela, Miguel Aguilar Santelises, Martha Moreno Lafont, Leopoldo Santos Argumedo, Vladimir Paredes Cervantes y Rubén López Santiago. "Human B cells are targets for Brucella abortus infection. (P3130)". Journal of Immunology 190, n.º 1_Supplement (1 de mayo de 2013): 186.12. http://dx.doi.org/10.4049/jimmunol.190.supp.186.12.
Texto completoTang, Yongmin, Lixia Li, Di Wang, Hongqiang Shen, Baiqin Qian, Chunfang Luo y Haizhong Zhang. "Study on the Preparation of the Immunotoxin 2E8-NCTD and Its Targeting Killing Effect In Vitro." Blood 110, n.º 11 (16 de noviembre de 2007): 4186. http://dx.doi.org/10.1182/blood.v110.11.4186.4186.
Texto completoIwasa, Masaki, Yasuo Miura, Aya Fujishiro, Sumie Fujii, Noriko Sugino, Satoshi Yoshioka, Akihiro Tamura et al. "Bortezomib Attenuates Adhesion of B Cell Precursor Acute Lymphoblastic Lleukemia Cells to Bone Marrow Mesenchymal Stromal/Stem Cells Via Regulating SPARC Expression". Blood 126, n.º 23 (3 de diciembre de 2015): 786. http://dx.doi.org/10.1182/blood.v126.23.786.786.
Texto completoHermanova, Ivana, Karel Valis, Karel Fiser, Hana Nuskova, Jan Trka y Julia Starkova. "L-Asparaginase Strongly Affects Bioenergetics in Leukemic Cells". Blood 120, n.º 21 (16 de noviembre de 2012): 779. http://dx.doi.org/10.1182/blood.v120.21.779.779.
Texto completoGu, Yan, Chunhua Song, Sinisa Dovat, Qinglong Guo, Qinyu Ge y Zheng Ge. "Oncogenesis of CRLF2 Overexpression and Effect of JAK2 Inhibitor in CRLF2 Overexpressed B-Cell Acute Lymphoblastic Leukemia". Blood 134, Supplement_1 (13 de noviembre de 2019): 2757. http://dx.doi.org/10.1182/blood-2019-125259.
Texto completoBarredo, Julio C., Sanja Altman-Hamandzic y Guy J. Leclerc. "Differences in Folylpoly-γ-Glutamate Synthetase (FPGS) Expression in Childhood ALL Result from Cell Lineage of Origin and Presence of Non-Random Translocations." Blood 104, n.º 11 (16 de noviembre de 2004): 2087. http://dx.doi.org/10.1182/blood.v104.11.2087.2087.
Texto completoBorges, Christopher M., Kevin Wasko, Jared M. Nasser, Kelly Donahue, Amanda Pfautz, Lincy P. Antony, Glenn Leary, Steven Sexton, Richard A. Morgan y Karrie K. Wong. "Preclinical Development of Edit-201, a Multigene Edited Healthy Donor NK Cell with Enhanced Anti-Tumor Function and Superior Serial Killing Activity in an Immunosuppressive Environment". Blood 136, Supplement 1 (5 de noviembre de 2020): 33. http://dx.doi.org/10.1182/blood-2020-139988.
Texto completoWang, Lingyan, Yue Zhang, Eden Anderson, Rajesh Kumar, Adam J. Lamble y Rimas J. Orentas. "CD22 CAR-T Induces Both CD19 and CD22 Surface Down-Modulation: Defining a Mechanism of Generalized Immune Evasion and the Effects of Epigenetic Modifiers". Blood 136, Supplement 1 (5 de noviembre de 2020): 22–23. http://dx.doi.org/10.1182/blood-2020-134930.
Texto completoBarredo, Julio C., Tingting Kinser y Guy J. Leclerc. "TEL/AML1 and E2A/PBX1 Tranlsocations Lead to Altered Folylpoly-γ-Glutamate Synthetase (FPGS) Expression in ALL." Blood 106, n.º 11 (16 de noviembre de 2005): 539. http://dx.doi.org/10.1182/blood.v106.11.539.539.
Texto completoTukaramrao, Diwakar Bastihalli, Arati Sharma, Dhimant Desai y Sinisa Dovat. "Abstract 6052: Metabolic consequences of casein kinase 2α inhibition in lymphoid leukemia". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 6052. http://dx.doi.org/10.1158/1538-7445.am2023-6052.
Texto completoBenito, Juliana, Yuexi Shi, Barbara Szymanska, Hernan Carol, Ingrid Bohem, Hongbo Lu, Sergej Konoplev et al. "Targeting the Leukemia-Associated Hypoxic Microenvironment with Hypoxia-Activated Prodrug PR-104". Blood 116, n.º 21 (19 de noviembre de 2010): 868. http://dx.doi.org/10.1182/blood.v116.21.868.868.
Texto completoTanaka, Yosuke, Masahito Kawazu, Satoshi Inoue, Shinya Kojima, Ueno Toshihide, Toshiaki Uno, Moe Tamura et al. "Chromatin Architecture Modulation in B-Cell Acute Lymphoblastic Leukemia Carrying DUX4 Fusions". Blood 134, Supplement_1 (13 de noviembre de 2019): 1240. http://dx.doi.org/10.1182/blood-2019-125207.
Texto completoCharkhizadeh, Samira, Mehdi Imani, Nematollah Gheibi, Fateme Shabaani, Akbar Nikpajouh y Mohammad R. Rezvany. "In Vitro Inhibitory Effect of Recombinant Human Calprotectin on Nalm6 Leukemia Cell Line". Anti-Cancer Agents in Medicinal Chemistry 20, n.º 8 (24 de julio de 2020): 951–62. http://dx.doi.org/10.2174/1871520620666200331101209.
Texto completoKaralewitz, Andrew, Natalie Czeryba, Yewei Xing, Derrik Germain, Philip Lapinski, Sheri Barnes, Mark Cameron et al. "Abstract 2835: Chimeric antigen receptor (CAR) T-cell generation for therapeutic testing in the disseminated NALM6 human B-cell acute lymphoblastic leukemia mouse model". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 2835. http://dx.doi.org/10.1158/1538-7445.am2022-2835.
Texto completoLeclerc, Gilles M., Guy J. Leclerc, Jeffim N. Kuznetsov y Julio C. Barredo. "PIM2 Upregulation Leads to Physiological Buffering of Metformin-Induced Cell Death Mediated by ER Stress/UPR in Acute Lymphoblastic Leukemia",. Blood 118, n.º 21 (18 de noviembre de 2011): 3496. http://dx.doi.org/10.1182/blood.v118.21.3496.3496.
Texto completoKohler, M. Eric, Zachary Walsh, Kole Degolier y Terry J. Fry. "Enhancing the Antigen-Sensitivity of the CD22 CAR through Modulation of the Affinity and Linker-Length of the Single-Chain Fragment Variable". Blood 136, Supplement 1 (5 de noviembre de 2020): 41–42. http://dx.doi.org/10.1182/blood-2020-143372.
Texto completoLeclerc, Guy J., Jianfeng Du, Joanna DeSalvo, Gilles M. Leclerc y Julio C. Barredo. "The BCR-ABL Fusion Protein Sensitizes Acute Lymphoblastic Leukemia to Apoptotic Death Induced by the Dual Glycolytic and Glycosylation Inhibitor 2-Deoxy-D-Glucose." Blood 120, n.º 21 (16 de noviembre de 2012): 2439. http://dx.doi.org/10.1182/blood.v120.21.2439.2439.
Texto completoSipol, Alexandra, Thomas Grünewald, Guenther Richter, Caroline Wernicke, Hans-Jochem Kolb, Torsten Haferlach y Stefan Burdach. "Overexpression of the Metabolic Stress Sensor and Proglycolytic Transcription Factor ΜLΧΙΡ Mediates Malignancy of Common Acute Lymphoblastic Leukemia in Vivo and Is Targetable By Allorestricted Peptide Specific T Cells". Blood 124, n.º 21 (6 de diciembre de 2014): 2436. http://dx.doi.org/10.1182/blood.v124.21.2436.2436.
Texto completoUeno, Shikiko, Jiayun Lu, He Jie, Ailing Li, XiaoXian Zhang, Leslie E. Silberstein, Jerome Ritz y Li Chai. "SALL4 Is a Key Survival Factor in Acute B-Cell Lymphoblastic Leukemia". Blood 118, n.º 21 (18 de noviembre de 2011): 2428. http://dx.doi.org/10.1182/blood.v118.21.2428.2428.
Texto completoXu, Bing, Manman Deng, Zhiwu Jiang, Jie Li, Kai Chen y Peng Li. "Role of Mitochondrial Apoptotic Pathway in Disulfiram/Copper Mixture-Induced Cell Apoptosis in Human B-Lineage Acute Lymphoblastic Leukemia in Vitro". Blood 126, n.º 23 (3 de diciembre de 2015): 4920. http://dx.doi.org/10.1182/blood.v126.23.4920.4920.
Texto completoZanjirband, Maryam, Soheila Rahgozar y Narges Aberuyi. "miR-16-5p enhances sensitivity to RG7388 through targeting PPM1D expression (WIP1) in Childhood Acute Lymphoblastic Leukemia". Cancer Drug Resistance 6, n.º 2 (2023): 242–56. http://dx.doi.org/10.20517/cdr.2022.113.
Texto completoMansilla-Soto, Jorge, Justin Eyquem, Sascha Haubner, Mohamad Hamieh, Judith Feucht, Noémie Paillon, Andres Zucchetti et al. "132 HLA-independent T cell receptors effectively target low abundance antigens". Journal for ImmunoTherapy of Cancer 9, Suppl 2 (noviembre de 2021): A142. http://dx.doi.org/10.1136/jitc-2021-sitc2021.132.
Texto completoKawamata, Norihiko, Fabienne Isken, Stefanie Goellner, C. Müller-Tidow y H. Phillip Koeffler. "ChIP-on-Chip Analysis Using Dominant Negative Form of PAX5 Fusion Gene Revealed Genes Associated with Tumorigenesis Were Directly Regulated by PAX5 in a Human B Cell Line, NALM6". Blood 112, n.º 11 (16 de noviembre de 2008): 3585. http://dx.doi.org/10.1182/blood.v112.11.3585.3585.
Texto completoMladenov, Emil, Katja Paul-Konietzko, Veronika Mladenova, Martin Stuschke y George Iliakis. "Increased Gene Targeting in Hyper-Recombinogenic LymphoBlastoid Cell Lines Leaves Unchanged DSB Processing by Homologous Recombination". International Journal of Molecular Sciences 23, n.º 16 (16 de agosto de 2022): 9180. http://dx.doi.org/10.3390/ijms23169180.
Texto completoXing, Dongxia, Wendy Fang, William K. Decker, Sufang Li, Simon N. Robinson, Hong Yang, David Steiner et al. "Ex Vivo Expansion of Cord Blood NK Cell Have In Vivo Efficacy Against Leukemia." Blood 110, n.º 11 (16 de noviembre de 2007): 2741. http://dx.doi.org/10.1182/blood.v110.11.2741.2741.
Texto completoMa, Xiao-Tong, Ya-Kun Mou, Yang-Yang Zhao, Nan Wang, Xiao-Yan Liu, Jing Yin, Yan-Ping Ma y Dan Guo. "Set7 Is Highly Expressed in B-Lineage Acute Lymphoblastic Leukemia Cells and Overexpression of Set7 Exhibits Antileukemia Effect". Blood 128, n.º 22 (2 de diciembre de 2016): 5088. http://dx.doi.org/10.1182/blood.v128.22.5088.5088.
Texto completoMardiana, Sherly, Olga Shestova, Stephan A. Grupp, Marco Ruella, David M. Barrett y Saar Gill. "Repurposing Bi-Specific Chimeric Antigen Receptor (CAR) Approach to Enhance CAR T Cell Activity Against Low Antigen Density Tumors". Blood 138, Supplement 1 (5 de noviembre de 2021): 1727. http://dx.doi.org/10.1182/blood-2021-146995.
Texto completoHlozkova, Katerina, Alpesh Thakker, Natividad Alquézar-Artieda, Marketa Zaliova, Jan Trka, Daniel A. Tennant y Julia Starkova. "Separate Roles of Asparagine and Glutamine in Cytostatic Effect of L-Asparaginase - Stable Isotope Tracing Approach". Blood 134, Supplement_1 (13 de noviembre de 2019): 2575. http://dx.doi.org/10.1182/blood-2019-127911.
Texto completoDu, Jianfeng, Joanna DeSalvo y Julio C. Barredo. "Mechanisms of Sensitivity of B-Precursor, T-Lineage and BCR/ABL Positive Acute Lymphoblastic Leukemia (ALL) to the Glycolytic Inhibitor 2-Deoxy-D-Glucose (2-DG)." Blood 114, n.º 22 (20 de noviembre de 2009): 3081. http://dx.doi.org/10.1182/blood.v114.22.3081.3081.
Texto completoQin, Haiying, Sang M. Nguyen, Sneha Ramakrishna, Samiksha Tarun, Lila Yang, Nicholas Peter Verdini, Waleed Haso y Terry J. Fry. "Novel CD19/CD22 Bicistronic Chimeric Antigen Receptors Outperform Single or Bivalent Cars in Eradicating CD19+CD22+, CD19-, and CD22- Pre-B Leukemia". Blood 130, Suppl_1 (7 de diciembre de 2017): 810. http://dx.doi.org/10.1182/blood.v130.suppl_1.810.810.
Texto completoSchramm, Joseph W., Melanie Ehudin, Bing He, Chingakham Singh, Daniel Bogush, Jeremy Hengst, Diwakar Bastihalli Tukaramrao, Arati Sharma, Dhimant Desai y Sinisa Dovat. "Abstract 3833: Leonurine derivatives as a potential novel therapeutic approach to acute lymphoblastic leukemias (ALL)". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 3833. http://dx.doi.org/10.1158/1538-7445.am2023-3833.
Texto completoJain, Nayan, Zeguo Zhao, Richard Koche, Yosi Gozlan, David Brocks, Tali Raveh-Sadka, Danny Wells et al. "SUV39H1 disruption imparts functional persistence to CD28-costimulated human CAR T cells". Journal of Immunology 208, n.º 1_Supplement (1 de mayo de 2022): 122.05. http://dx.doi.org/10.4049/jimmunol.208.supp.122.05.
Texto completoSingh, Nathan, Noelle V. Frey, Boris Engels, David M. Barrett, Olga Shestova, Pranali Ravikumar, Amy Shyu et al. "Single Chain Variable Fragment Linker Length Regulates CAR Biology and T Cell Efficacy". Blood 134, Supplement_1 (13 de noviembre de 2019): 247. http://dx.doi.org/10.1182/blood-2019-131024.
Texto completoSingh, Nathan, Olga Shestova, Katharina Hayer, Albert Hong, Pranali Ravikumar, Atushi Hoshino, Ophir Shalem et al. "CAR T Cell Cytotoxicity Is Dependent on Death Receptor-Driven Apoptosis". Blood 132, Supplement 1 (29 de noviembre de 2018): 698. http://dx.doi.org/10.1182/blood-2018-99-117328.
Texto completoKitanaka, Akira, Hiroyuki Mano, Mary Ellen Conley y Dario Campana. "Expression and Activation of the Nonreceptor Tyrosine Kinase Tec in Human B Cells". Blood 91, n.º 3 (1 de febrero de 1998): 940–48. http://dx.doi.org/10.1182/blood.v91.3.940.
Texto completoKitanaka, Akira, Hiroyuki Mano, Mary Ellen Conley y Dario Campana. "Expression and Activation of the Nonreceptor Tyrosine Kinase Tec in Human B Cells". Blood 91, n.º 3 (1 de febrero de 1998): 940–48. http://dx.doi.org/10.1182/blood.v91.3.940.940_940_948.
Texto completoJain, Nayan, Zeguo Zhao, Richard Koche, Yosi Gozlan, David Brocks, Tali Raveh-Sadka, Danny Wells et al. "Abstract 5583: SUV39H1 disruption enhances the persistence and anti-tumor efficacy of CD28-costimulated human CAR T cells". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 5583. http://dx.doi.org/10.1158/1538-7445.am2022-5583.
Texto completoSaunders, Philip O., Kenneth F. Bradstock y Linda J. Bendall. "Dose Escalated RAD001 (Everolimus) Enhances Chemosensitivity in Precursor-B Acute Lymphoblastic Leukemia, through a JNK Dependent Suppression of Cell Cycle Checkpoint Regulation." Blood 112, n.º 11 (16 de noviembre de 2008): 1604. http://dx.doi.org/10.1182/blood.v112.11.1604.1604.
Texto completoMorisot, Nadege, Sarah Wadsworth, Tina Davis, Nicole Dailey, Kyle Hansen, Denise Gonzalez, Nafees Rahman et al. "127 Preclinical evaluation of NKX019, a CD19-targeting CAR NK Cell". Journal for ImmunoTherapy of Cancer 8, Suppl 3 (noviembre de 2020): A140. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0127.
Texto completoIto, Chihiro, Takuya Matsui, Eri Noda, Nijsiri Ruangrungsi y Masataka Itoigawa. "Biphenyl Derivatives from Garcinia Schomburgkiana and the Cytotoxicity of the Isolated Compounds". Natural Product Communications 8, n.º 9 (septiembre de 2013): 1934578X1300800. http://dx.doi.org/10.1177/1934578x1300800921.
Texto completoSarno, Jolanda, Pablo Domizi, Yuxuan Liu, Milton Merchant, Dorra Jedoui, Astraea Jager, Andrea Biondi, Giuseppe Gaipa, Alessio Felice Bava y Kara L. Davis. "Glucocorticoid-Resistant B-Cell Acute Lymphoblastic Leukemic Cells Can be Targeted By BCR-Signaling Inhibition". Blood 138, Supplement 1 (5 de noviembre de 2021): 617. http://dx.doi.org/10.1182/blood-2021-150356.
Texto completoJain, Nayan, Zeguo Zhao, Archana S. Iyer, Michael Lopez, Judith Feucht, Richard P. Koche, Yingqian Zhan y Michel Sadelain. "Loss of TET2 Uncouples Proliferative and Effector Functions in CAR T Cells". Blood 136, Supplement 1 (5 de noviembre de 2020): 1. http://dx.doi.org/10.1182/blood-2020-142957.
Texto completoArnaud, Marie-Pierre, Audrey Vallée, Guillaume Robert, Anne-Gaelle Rio, Elisabetta Dondi, Jacinthe Bonneau, Christine LE ROY et al. "Disruption Of CD9 Expression Affects Adhesion, Migration and Engraftment Of Pre-B Lymphocytes". Blood 122, n.º 21 (15 de noviembre de 2013): 1222. http://dx.doi.org/10.1182/blood.v122.21.1222.1222.
Texto completoIwanski, Gabriela B., Nils H. Thoennissen, Joy Nakitandwe, Patricia Lin, Norihiko Kawamata, Rahul Nahar, Parham Ramezani-Rad et al. "Dominant-Negative Impact of PAX5/TEL on Downstream Targets of PAX5 and Essential Pre-B Cell Receptor Genes". Blood 116, n.º 21 (19 de noviembre de 2010): 3231. http://dx.doi.org/10.1182/blood.v116.21.3231.3231.
Texto completoPark, S., A. Register, H. Y. Lee, G. Lutzny-Geier, M. Aigner, M. Andreas, G. Schett, D. Borie, J. Chung y C. Kaplan. "POS0007 KYV-101, A FULLY HUMAN CD19 CAR T CELL GENERATED FROM AUTOIMMUNE PATIENT LYMPHOCYTES, DEMONSTRATES CAR-MEDIATED AND CD19-DEPENDENT ACTIVITY AGAINST AUTOLOGOUS B CELLS". Annals of the Rheumatic Diseases 82, Suppl 1 (30 de mayo de 2023): 208.2–209. http://dx.doi.org/10.1136/annrheumdis-2023-eular.6228.
Texto completoKhan, Naveed I., Kenneth Francis Bradstock y Linda J. Bendall. "The Wnt Pathway Modulates Expression of Growth and Survival Genes in Acute Lymphoblastic Leukemia Cells." Blood 108, n.º 11 (16 de noviembre de 2006): 1850. http://dx.doi.org/10.1182/blood.v108.11.1850.1850.
Texto completoLiu, Xiaojun, David M. Barrett, Shuguang Jiang, Chongyun Fang, Stephan A. Grupp, Carl H. June y Yangbing Zhao. "Improved Anti-Leukemia Activities of Adoptively Transferred T Cells Expressing Bites". Blood 126, n.º 23 (3 de diciembre de 2015): 4431. http://dx.doi.org/10.1182/blood.v126.23.4431.4431.
Texto completoDraper, David W., Derrik Germain, Stacey Roys, Olivia Nelson y Scott Wise. "Abstract 2749: Preclinical assessment of chimeric antigen receptor (CAR) T persistence and functionality in the disseminated NALM6-Luc human B cell acute lymphoblastic leukemia (ALL) model". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 2749. http://dx.doi.org/10.1158/1538-7445.am2023-2749.
Texto completoDolinski, Brian, Vandana Chaturvedi, Daryl Humes, Christina Proano, Mariliis Ott, Jesus Moreno, Garrett Zipp et al. "Abstract 2734: Modulation of resting T cell status to enhance transduction and CAR T expansion following exposure to CD8-targeted fusosomes". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 2734. http://dx.doi.org/10.1158/1538-7445.am2023-2734.
Texto completoLeclerc, Guy J. y Julio C. Barredo. "Histone Deacetylase Inhibitor Induces FPGS mRNA Expression in Childhood B-Precursor and T Acute Lymphoblastic Leukemia: Implication of Combination Therapy with Methotrexate To Enhance Cytotoxicity." Blood 110, n.º 11 (16 de noviembre de 2007): 864. http://dx.doi.org/10.1182/blood.v110.11.864.864.
Texto completo